Ulcerative colitis and colorectal cancer have a connection, but you can lower your risk of the latter through regular cancer ...

People with inflammatory bowel disease, like ulcerative colitis, are 2 to 3 times more likely to develop blood clots than ...

When Phyllis Burk was diagnosed with Crohn’s disease nearly 50 years ago, it wasn’t as simple as looking up information ...

Highly-Specific Allosteric ACLY Inhibitor Designed to Target Liver and Bile Duct Injury, Inflammation, and Fibrosis Associated with Primary ...

A 29-year-old man undergoes a total proctocolectomy with end-to-end ileostomy after 2 years of surveillance for ulcerative colitis.

Therapeutic drug monitoring is associated with better treatment durability among children with inflammatory bowel diseases.

The updated indication for the JAK inhibitor allows use in patients with moderately to severely active ulcerative colitis and ...

The FDA has approved an updated indication for upadacitinib (Rinvoq; AbbVie) in inflammatory bowel disease (IBD), allowing its use in adults with moderately to severely active ulcerative colitis or ...

ABIVAX Société Anonyme's Obefazimod shows robust efficacy and differentiation in early Phase 3 trials. Click here to read why ...

People with ulcerative colitis, a form of IBD, who were taking the new drug Omvoh and achieved clinical remission after 1 ...

Once-daily oral obefazimod met the primary endpoint of clinical remission at 8 weeks in a highly refractory population of ...

The Food and Drug Administration (FDA) has expanded the approval of Simponi ® (golimumab) to include pediatric patients weighing at least 15kg with moderate to severely active ulcerative colitis (UC).